Clinical trials
Observational Recurrence trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
77 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 12 |
| 2021 | 2 |
| 2022 | 9 |
| 2023 | 1 |
| 2024 | 11 |
| 2025 | 6 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 32 |
| Recruiting | 16 |
| Completed | 15 |
| Not yet recruiting | 10 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 4 |
| Peking University Third Hospital | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2 |
| Chen Xiaoping | 2 |
| First Affiliated Hospital of Harbin Medical University | 2 |
| Lei Li | 2 |
| Sun Yat-sen University | 2 |
| Tongji Hospital | 2 |
| Zhujiang Hospital | 2 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 77 |
| Carcinoma, Hepatocellular | 7 |
| Colorectal Neoplasms | 7 |
| Neoplasm Metastasis | 6 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Biliary Tract Neoplasms | 2 |
| Carcinoma, Transitional Cell | 2 |
| Disease | 2 |
| Kidney Calculi | 2 |
Trials
Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.